Maynard Um
-
-
-
-
-
-
-
Akari Therapeutics outlines 2025 progress in shareholder letter
-
-
-
-
-
-
-
AKARI Therapeutics files patent for cancer ADC platform
-
-
-
-
-
-
-
Akari Therapeutcis (AKTX) Appoints Mark F. Kubik as Head of Business Development - Oncology
-
-
-
-
-
-
-
Akari Therapeutcis (AKTX): Rob Bazemore Appointed to the Board of Directors of Akari Therapeutics
418,491 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

